Drug Approval | December 13, 2022
European Commission approves SPEVIGO for generalized pustular psoriasis flares
EC grants conditional marketing authorization based on the EFFISAYIL trial
EC grants conditional marketing authorization based on the EFFISAYIL trial
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
They also released the Operational Guidelines for Wellness activities at AB-HWCs
Since inception, more than 3.6 crore pregnant women have received comprehensive ANC under this programme across all states and UTs
As a result, Imago will become a subsidiary of Merck.
Company to open new headquarters in 2024
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
The 9th World Ayurveda Congress and Arogya Expo 2022 aims to showcase the efficacy and strength of the AYUSH systems of medicine at the global level
The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
Subscribe To Our Newsletter & Stay Updated
